GSS
GENETICSIG FPO [GSS]
Healthcare · ASX Small Cap
$0.0890 +11.2%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical70
Catalyst53
Sentiment50
Fundamental76
Momentum24
Risk Gate50
Get alerts when GSS's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- On a tear — up 12.7% over the last 5 days
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Strong cash runway (12 quarters)
- Low P/S ratio (1.0x)
- EPS estimates revised downward (-6pts)
- Near 52-week low (3% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (52%)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 79% over the past year
- Poor risk-adjusted returns — Sharpe of -1.7 means lots of volatility for not much reward
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-57%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-3.68%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about GSS
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Change in substantial holding
NONE Change in substantial holding
NONE Change in substantial holding
Announcement tone +3pts
Recent ASX Announcements
| 2026-03-17 | Change in substantial holding |
| 2026-03-16 | Change in substantial holding |
| 2026-03-12 | Change in substantial holding |
| 2026-03-10 | Change in substantial holding |
| 2026-02-25 | 1H FY26 Results Presentation PRICE SENSITIVE |
Key Metrics
$20.2M
Market Cap
560K
Avg Volume
0.4x
Vol Ratio
$0.07 — $0.69
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-22.8%
ROE
-56.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 76% |
| L | Leader vs Laggard | laggard | RS: -14 |
| I | Institutional Sponsorship | pass | Inst: 52% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #64 of 117 · Sector avg: 46
View all Healthcare signals →Track GSS and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required